Stock QTTB Q32 BIO INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Q32 Bio Inc.

Equities

QTTB

US7469641051

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
29.04 USD +3.64% Intraday chart for Q32 Bio Inc. +17.00% +165.35%
Apr. 11 Oppenheimer Initiates Coverage on Q32 Bio With Outperform Rating, $50 Price Target MT
Apr. 03 Q32 Bio Inc. Appoints Lee Kalowski as Chief Financial Officer CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Oppenheimer Initiates Coverage on Q32 Bio With Outperform Rating, $50 Price Target
MT
Q32 Bio Appoints Lee Kalowski as President & Chief Financial Officer
PR
Q32 Bio Inc. Appoints Lee Kalowski as Chief Financial Officer
CI
Piper Sandler Initiates Q32 Bio With Overweight Rating, $45 Price Target
MT
Q32 Bio Inc.(NasdaqGM:QTTB) added to NASDAQ Composite Index
CI
Homology Medicines, Inc.(NasdaqGS:FIXX) dropped from NASDAQ Composite Index
CI
Q32 Bio Inc. announced that it has received $42 million in funding from a group of investors
CI
Q32 Bio Inc. completed the acquisition of Homology Medicines, Inc. from 5AM Venture Management, LLC, Arch Venture Fund VIII, L.P. and ARCH Venture Fund VIII Overage, L.P. managed by Arch Venture Partners, L.P., Pfizer Inc. and TLS Beta Pte. Ltd. in a reverse merger transaction.
CI
North American Morning Briefing : Markets on Hold -2-
DJ
Homology Medicines Declares Distribution to Common Stockholders
AQ
Homology Medicines, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
HOMOLOGY MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc. - FIXX
BU
Neurogene Names Julie Jordan as Chief Medical Officer
MT
Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency
AQ
HOMOLOGY MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc. - FIXX
BU
FIXX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Homology Medicines, Inc. Is Fair to Shareholders
BU
Q32 Bio and Homology Medicines Announce Merger Agreement
PR
Q32 Bio and Homology Medicines Announce Merger Agreement
AQ
Q32 Bio Inc. announced that it expects to receive $42 million in funding from a group of investors
CI
Homology Medicines: Q3 Earnings Snapshot
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. QTTB Stock
  4. News Q32 Bio Inc.